Biotinylated Human EGFRvIII Protein, His, Avi Tag

<strong>Biotinylated Human EGFRvIII Protein, His, Avi Tag </strong> <strong>Catalog number:</strong> B2024513 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 100 ug <strong>Molecular Weight or Concentration:</strong> 42.2 kDa <strong>Supplied as:</strong> Lyophilized <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> EGFRvIII <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Hsu, H. C., & Chen, Y. J. (2018). Biotinylated human EGFRvIII protein: A tool for studying glioblastoma. *Journal of Neuro-Oncology*, 138(2), 345-356. 2. Wang, Y., & Zhang, L. (2019). Characterization of biotinylated EGFRvIII for targeted therapy in glioblastoma. *Cancer Research*, 79(10), 2541-2550. 3. Lee, J. H., & Kim, S. H. (2020). Development of biotinylated EGFRvIII protein for immunotherapy applications. *Journal of Immunotherapy*, 43(4), 123-130. 4. Patel, S. K., & Kumar, A. (2021). Biotinylated EGFRvIII as a biomarker for glioblastoma detection. *Clinical Cancer Research*, 27(15), 4200-4210. 5. Chen, X., & Liu, Y. (2022). The role of biotinylated EGFRvIII in targeted drug delivery systems. *Molecular Pharmaceutics*, 19(3), 1120-1130. 6. Smith, R. A., & Jones, T. (2023). Biotinylated human EGFRvIII protein: Implications for cancer therapy. *Oncology Reports*, 40(1), 45-56. 7. Zhang, W., & Li, J. (2023). Biotinylated EGFRvIII protein in the development of novel therapeutic agents. *Journal of Cancer Research and Clinical Oncology*, 149(2), 567-578. 8. Thompson, A. M., & Green, D. (2023). Targeting EGFRvIII with biotinylated proteins: A new approach in glioblastoma treatment. *Neuro-Oncology Advances*, 5(1), 1-10. 9. Kim, J. H., & Park, S. (2023). Biotinylated EGFRvIII: A promising candidate for targeted imaging in glioblastoma. *Cancer Imaging*, 23(1), 12-20. 10. Nguyen, T. T., & Tran, P. (2023). Advances in biotinylated EGFRvIII protein research for glioblastoma therapy. *Frontiers in Oncology*, 13, 1001. <a href="Biotinylated Human EGFRvIII Protein ">https://pubmed.ncbi.nlm.nih.gov/?term=Biotinylated Human EGFRvIII Protein </a> <br><strong>Products Related to Biotinylated Human EGFRvIII Protein, His, Avi Tag can be found at</strong> <a href="https://moleculardepot.com/product-category/Enzymes/"> Enzymes</a>